LOS ANGELES, Aug 23 (Reuters) - ImClone Systems Inc said on Thursday that its senior vice president of finance, Ana Stancic, will resign on Sept. 30. Stancic was responsible for the company's finance department, information technology and internal audit, ImClone, which makes cancer drug Erbitux, said in a regulatory filing.
